Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cercamed is a medical technology company and a subsidiary of Masimo Corporation, focused on the development of non-invasive monitoring solutions. The company specializes in advanced sensor technologies and signal processing algorithms that allow for the measurement of blood constituents such as glucose, hemoglobin, and oxygen saturation without invasive procedures. Its innovations are primarily integrated into the Masimo Rainbow SET platform, which is used globally in clinical settings to monitor patients for conditions like anemia, diabetes, and respiratory distress. By providing real-time, continuous data, Cercamed's technology aims to improve patient outcomes and reduce the costs associated with traditional blood testing. The company remains a key entity in Masimo's portfolio for expanding the capabilities of pulse oximetry and physiological sensing.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cercamed.